Cargando…
Statement on in vitro protein digestibility tests in allergenicity and protein safety assessment of genetically modified plants
This statement supplements and updates the GMO Panel guidance document on allergenicity of genetically modified (GM) plants published in 2017. In that guidance document, the GMO Panel considered that additional investigations on in vitro protein digestibility were needed before providing any additio...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7801955/ https://www.ncbi.nlm.nih.gov/pubmed/33473251 http://dx.doi.org/10.2903/j.efsa.2021.6350 |
_version_ | 1783635683070443520 |
---|---|
author | Naegeli, Hanspeter Bresson, Jean‐Louis Dalmay, Tamas Dewhurst, Ian Crawford Epstein, Michelle M Firbank, Leslie George Guerche, Philippe Hejatko, Jan Moreno, Francisco Javier Mullins, Ewen Nogué, Fabien Rostoks, Nils Sánchez Serrano, Jose Juan Savoini, Giovanni Veromann, Eve Veronesi, Fabio Dumont, Antonio Fernandez |
author_facet | Naegeli, Hanspeter Bresson, Jean‐Louis Dalmay, Tamas Dewhurst, Ian Crawford Epstein, Michelle M Firbank, Leslie George Guerche, Philippe Hejatko, Jan Moreno, Francisco Javier Mullins, Ewen Nogué, Fabien Rostoks, Nils Sánchez Serrano, Jose Juan Savoini, Giovanni Veromann, Eve Veronesi, Fabio Dumont, Antonio Fernandez |
collection | PubMed |
description | This statement supplements and updates the GMO Panel guidance document on allergenicity of genetically modified (GM) plants published in 2017. In that guidance document, the GMO Panel considered that additional investigations on in vitro protein digestibility were needed before providing any additional recommendations in the form of guidance to applicants. Thus, an interim phase was proposed to assess the utility of an enhanced in vitro digestion test, as compared to the classical pepsin resistance test. Historically, resistance to degradation by pepsin using the classical pepsin resistance test has been considered as additional information, in a weight‐of‐evidence approach, for the assessment of allergenicity and toxicity of newly expressed proteins in GM plants. However, more recent evidence does not support this test as a good predictor of allergenic potential for hazard. Furthermore, there is a need for more reliable systems to predict the fate of the proteins in the gastrointestinal tract and how they interact with the relevant human cells. Nevertheless, the classical pepsin resistance test can still provide some information on the physicochemical properties of novel proteins relating to their stability under acidic conditions. But other methods can be used to obtain data on protein's structural and/or functional integrity. It is acknowledged that the classical pepsin resistance test is embedded into international guidelines, e.g. Codex Alimentarius and Regulation (EU) No 503/2013. For future development, a deeper understanding of protein digestion in the gastrointestinal tract could enable the framing of more robust strategies for the safety assessment of proteins. Given the high complexity of the digestion and absorption process of dietary proteins, it is needed to clarify and identify the aspects that could be relevant to assess potential risks of allergenicity and toxicity of proteins. To this end, a series of research questions to be addressed are also formulated in this statement. |
format | Online Article Text |
id | pubmed-7801955 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-78019552021-01-19 Statement on in vitro protein digestibility tests in allergenicity and protein safety assessment of genetically modified plants Naegeli, Hanspeter Bresson, Jean‐Louis Dalmay, Tamas Dewhurst, Ian Crawford Epstein, Michelle M Firbank, Leslie George Guerche, Philippe Hejatko, Jan Moreno, Francisco Javier Mullins, Ewen Nogué, Fabien Rostoks, Nils Sánchez Serrano, Jose Juan Savoini, Giovanni Veromann, Eve Veronesi, Fabio Dumont, Antonio Fernandez EFSA J Statement This statement supplements and updates the GMO Panel guidance document on allergenicity of genetically modified (GM) plants published in 2017. In that guidance document, the GMO Panel considered that additional investigations on in vitro protein digestibility were needed before providing any additional recommendations in the form of guidance to applicants. Thus, an interim phase was proposed to assess the utility of an enhanced in vitro digestion test, as compared to the classical pepsin resistance test. Historically, resistance to degradation by pepsin using the classical pepsin resistance test has been considered as additional information, in a weight‐of‐evidence approach, for the assessment of allergenicity and toxicity of newly expressed proteins in GM plants. However, more recent evidence does not support this test as a good predictor of allergenic potential for hazard. Furthermore, there is a need for more reliable systems to predict the fate of the proteins in the gastrointestinal tract and how they interact with the relevant human cells. Nevertheless, the classical pepsin resistance test can still provide some information on the physicochemical properties of novel proteins relating to their stability under acidic conditions. But other methods can be used to obtain data on protein's structural and/or functional integrity. It is acknowledged that the classical pepsin resistance test is embedded into international guidelines, e.g. Codex Alimentarius and Regulation (EU) No 503/2013. For future development, a deeper understanding of protein digestion in the gastrointestinal tract could enable the framing of more robust strategies for the safety assessment of proteins. Given the high complexity of the digestion and absorption process of dietary proteins, it is needed to clarify and identify the aspects that could be relevant to assess potential risks of allergenicity and toxicity of proteins. To this end, a series of research questions to be addressed are also formulated in this statement. John Wiley and Sons Inc. 2021-01-12 /pmc/articles/PMC7801955/ /pubmed/33473251 http://dx.doi.org/10.2903/j.efsa.2021.6350 Text en © 2021 European Food Safety Authority. EFSA Journal published by John Wiley and Sons Ltd on behalf of European Food Safety Authority. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited and no modifications or adaptations are made. |
spellingShingle | Statement Naegeli, Hanspeter Bresson, Jean‐Louis Dalmay, Tamas Dewhurst, Ian Crawford Epstein, Michelle M Firbank, Leslie George Guerche, Philippe Hejatko, Jan Moreno, Francisco Javier Mullins, Ewen Nogué, Fabien Rostoks, Nils Sánchez Serrano, Jose Juan Savoini, Giovanni Veromann, Eve Veronesi, Fabio Dumont, Antonio Fernandez Statement on in vitro protein digestibility tests in allergenicity and protein safety assessment of genetically modified plants |
title | Statement on in vitro protein digestibility tests in allergenicity and protein safety assessment of genetically modified plants |
title_full | Statement on in vitro protein digestibility tests in allergenicity and protein safety assessment of genetically modified plants |
title_fullStr | Statement on in vitro protein digestibility tests in allergenicity and protein safety assessment of genetically modified plants |
title_full_unstemmed | Statement on in vitro protein digestibility tests in allergenicity and protein safety assessment of genetically modified plants |
title_short | Statement on in vitro protein digestibility tests in allergenicity and protein safety assessment of genetically modified plants |
title_sort | statement on in vitro protein digestibility tests in allergenicity and protein safety assessment of genetically modified plants |
topic | Statement |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7801955/ https://www.ncbi.nlm.nih.gov/pubmed/33473251 http://dx.doi.org/10.2903/j.efsa.2021.6350 |
work_keys_str_mv | AT statementoninvitroproteindigestibilitytestsinallergenicityandproteinsafetyassessmentofgeneticallymodifiedplants AT naegelihanspeter statementoninvitroproteindigestibilitytestsinallergenicityandproteinsafetyassessmentofgeneticallymodifiedplants AT bressonjeanlouis statementoninvitroproteindigestibilitytestsinallergenicityandproteinsafetyassessmentofgeneticallymodifiedplants AT dalmaytamas statementoninvitroproteindigestibilitytestsinallergenicityandproteinsafetyassessmentofgeneticallymodifiedplants AT dewhurstiancrawford statementoninvitroproteindigestibilitytestsinallergenicityandproteinsafetyassessmentofgeneticallymodifiedplants AT epsteinmichellem statementoninvitroproteindigestibilitytestsinallergenicityandproteinsafetyassessmentofgeneticallymodifiedplants AT firbanklesliegeorge statementoninvitroproteindigestibilitytestsinallergenicityandproteinsafetyassessmentofgeneticallymodifiedplants AT guerchephilippe statementoninvitroproteindigestibilitytestsinallergenicityandproteinsafetyassessmentofgeneticallymodifiedplants AT hejatkojan statementoninvitroproteindigestibilitytestsinallergenicityandproteinsafetyassessmentofgeneticallymodifiedplants AT morenofranciscojavier statementoninvitroproteindigestibilitytestsinallergenicityandproteinsafetyassessmentofgeneticallymodifiedplants AT mullinsewen statementoninvitroproteindigestibilitytestsinallergenicityandproteinsafetyassessmentofgeneticallymodifiedplants AT noguefabien statementoninvitroproteindigestibilitytestsinallergenicityandproteinsafetyassessmentofgeneticallymodifiedplants AT rostoksnils statementoninvitroproteindigestibilitytestsinallergenicityandproteinsafetyassessmentofgeneticallymodifiedplants AT sanchezserranojosejuan statementoninvitroproteindigestibilitytestsinallergenicityandproteinsafetyassessmentofgeneticallymodifiedplants AT savoinigiovanni statementoninvitroproteindigestibilitytestsinallergenicityandproteinsafetyassessmentofgeneticallymodifiedplants AT veromanneve statementoninvitroproteindigestibilitytestsinallergenicityandproteinsafetyassessmentofgeneticallymodifiedplants AT veronesifabio statementoninvitroproteindigestibilitytestsinallergenicityandproteinsafetyassessmentofgeneticallymodifiedplants AT dumontantoniofernandez statementoninvitroproteindigestibilitytestsinallergenicityandproteinsafetyassessmentofgeneticallymodifiedplants |